Related Content
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one ...
September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm ...
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...
New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the ...
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical ...
July 17, 2019 — Abbott has received U.S. Food and Drug Administration (FDA) approval for the most advanced MitraClip ...